Jul 25 (Reuters)-
Kainos Laboratories Inc
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
3 months ended 3 months ended Year to
Jun 30, 2025 Jun 30, 2024 Mar 31, 2026
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 1.43 1.30 5.50
(+10.4 pct) (+8.9 pct) (+3.7 pct)
Operating 256 mln 266 mln 850 mln
(-3.7 pct) (+27.2 pct) (+3.2 pct)
Recurring 258 mln 266 mln 850 mln
(-2.9 pct) (+26.3 pct) (+2.6 pct)
Net 183 mln 187 mln 600 mln
(-2.2 pct) (+30.5 pct) (-6.4 pct)
EPS 43.57 yen 44.54 yen 142.33 yen
Ann Div 35.00 yen 32.00 yen
-Q2 div NIL NIL
-Q4 div 35.00 yen 32.00 yen
NOTE - Kainos Laboratories Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4556.T